- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term studies of treatments for type 2 diabetes
Authors
Keywords
-
Journal
POSTGRADUATE MEDICINE
Volume 129, Issue 3, Pages 352-365
Publisher
Informa UK Limited
Online
2016-11-24
DOI
10.1080/00325481.2017.1265417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
- (2016) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study
- (2016) Robert R. Henry et al. Diabetes Technology & Therapeutics
- Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial
- (2016) Daniël H van Raalte et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Intensive Therapy in Newly Diagnosed Type 2 Diabetes
- (2016) Lindsay B. Harrison et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
- (2015) Rafael Simó et al. Cardiovascular Diabetology
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
- (2015) DIABETES CARE
- Evaluation of the Long-Term Durability and Glycemic Control of Fasting Plasma Glucose and Glycosylated Hemoglobin for Pioglitazone in Japanese Patients with Type 2 Diabetes
- (2015) Frances Stringer et al. Diabetes Technology & Therapeutics
- Five-Year Efficacy and Safety Data of Exenatide Once Weekly
- (2015) Carol H. Wysham et al. MAYO CLINIC PROCEEDINGS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer and bone fractures in observational follow-up of the RECORD study
- (2014) Nigel P. Jones et al. ACTA DIABETOLOGICA
- Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial
- (2014) DIABETES CARE
- Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
- (2014) Julio Rosenstock et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
- (2014) Michaela Diamant et al. Lancet Diabetes & Endocrinology
- Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
- (2014) Viveca Ritsinger et al. Lancet Diabetes & Endocrinology
- Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
- (2013) Richard G. Bach et al. CIRCULATION
- Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
- (2013) Markolf Hanefeld et al. Current Diabetes Reports
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Observational follow-up of the PROactive study: a 6-year update
- (2013) E. Erdmann et al. DIABETES OBESITY & METABOLISM
- Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes
- (2013) J. Rosenstock et al. DIABETIC MEDICINE
- Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial
- (2013) J. de Jager et al. JOURNAL OF INTERNAL MEDICINE
- -Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
- (2012) L. B. Harrison et al. DIABETES CARE
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
- (2012) Baptist Gallwitz et al. LANCET
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
- (2011) J. M. Lachin et al. Clinical Journal of the American Society of Nephrology
- Effects of Rosiglitazone, Glyburide, and Metformin on -Cell Function and Insulin Sensitivity in ADOPT
- (2011) S. E. Kahn et al. DIABETES
- Effects of Exenatide on Measures of -Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
- (2011) M. C. Bunck et al. DIABETES CARE
- Long-Term Effects of Pioglitazone on Carotid Atherosclerosis in Japanese Patients with Type 2 Diabetes without a Recent History of Macrovascular Morbidity
- (2011) Yoshimitsu Yamasaki et al. Journal of Atherosclerosis and Thrombosis
- The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial
- (2010) S. Zoungas et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
- (2010) M. Komajda et al. EUROPEAN HEART JOURNAL
- Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
- (2010) Bernard Charbonnel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
- (2009) Kohei Kaku et al. CURRENT MEDICAL RESEARCH AND OPINION
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
- (2009) M. C. Bunck et al. DIABETES CARE
- Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
- (2009) A. J. Scheen et al. DIABETIC MEDICINE
- Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
- (2009) J. Rosenstock et al. DIABETOLOGIA
- Liver Safety in Patients with Type 2 Diabetes Treated with Pioglitazone
- (2009) Keith G. Tolman et al. DRUG SAFETY
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)
- (2008) Robert Wilcox et al. AMERICAN HEART JOURNAL
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up
- (2007) M. Alvarsson et al. DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now